BDBM451085 N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-::US10676479, Example 115

SMILES: Cc1ccc(cn1)-c1ncn2c(NCc3c4CCOc4ccc3F)ncc(-c3cccnc3C)c12

InChI Key: InChIKey=AZVTZJGVTDJFBH-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 451085   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Polycomb Repressive Complex 2 (PRC2) (Homo sapiens (Human))	BDBM451085 (N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)- |...) Show SMILES Cc1ccc(cn1)-c1ncn2c(NCc3c4CCOc4ccc3F)ncc(-c3cccnc3C)c12 Show InChI InChI=1S/C27H23FN6O/c1-16-5-6-18(12-30-16)25-26-22(19-4-3-10-29-17(19)2)14-32-27(34(26)15-33-25)31-13-21-20-9-11-35-24(20)8-7-23(21)28/h3-8,10,12,14-15H,9,11,13H2,1-2H3,(H,31,32)	PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.20	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description To assess the compounds' potency in the EED-H3K27Me3 competition binding assay, compounds were serially diluted 3-fold in DMSO to obtain a total ...				US Patent US10676479 (2020)
					More data for this Ligand-Target Pair
Polycomb Repressive Complex 2 (PRC2) (Homo sapiens (Human))	BDBM451085 (N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)- |...) Show SMILES Cc1ccc(cn1)-c1ncn2c(NCc3c4CCOc4ccc3F)ncc(-c3cccnc3C)c12 Show InChI InChI=1S/C27H23FN6O/c1-16-5-6-18(12-30-16)25-26-22(19-4-3-10-29-17(19)2)14-32-27(34(26)15-33-25)31-13-21-20-9-11-35-24(20)8-7-23(21)28/h3-8,10,12,14-15H,9,11,13H2,1-2H3,(H,31,32)	PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of eight or twelve concentrat...				US Patent US10676479 (2020)
					More data for this Ligand-Target Pair
Polycomb Repressive Complex 2 (PRC2) (Homo sapiens (Human))	BDBM451085 (N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)- |...) Show SMILES Cc1ccc(cn1)-c1ncn2c(NCc3c4CCOc4ccc3F)ncc(-c3cccnc3C)c12 Show InChI InChI=1S/C27H23FN6O/c1-16-5-6-18(12-30-16)25-26-22(19-4-3-10-29-17(19)2)14-32-27(34(26)15-33-25)31-13-21-20-9-11-35-24(20)8-7-23(21)28/h3-8,10,12,14-15H,9,11,13H2,1-2H3,(H,31,32)	PDB UniProtKB/SwissProt antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	17.6	n/a	n/a	n/a	n/a	n/a	n/a
Novartis AG US Patent					Assay Description Representative compounds of the present invention were serially and separately diluted 3-fold in DMSO to obtain a total of eight or twelve concentrat...				US Patent US10676479 (2020)
					More data for this Ligand-Target Pair